Our findings are consistent with prior research indicating a significant rise in Bax and a reduction in Bcl-2 mRNA expression levels within PBMCs of patients with MDD, especially those at high risk for suicide, relative to healthy controls [5]. This evidence concerns the gene BAX and major depressive disorder.